According to Kamada
's latest financial reports the company has a price-to-book ratio of 1.22.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.44 | 41.24% |
2022-12-31 | 1.02 | -38.82% |
2021-12-31 | 1.67 | 3.78% |
2020-12-31 | 1.61 | -21.24% |
2019-12-31 | 2.04 | 14.7% |
2018-12-31 | 1.78 | -16.73% |
2017-12-31 | 2.14 | -28.19% |
2016-12-31 | 2.98 | 41.9% |
2015-12-31 | 2.10 | 26.46% |
2014-12-31 | 1.66 | -71.53% |
2013-12-31 | 5.82 | -32.58% |
2012-12-31 | 8.64 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Vertex Pharmaceuticals VRTX | 5.85 | 379.66% | ๐บ๐ธ USA |
Compugen CGEN | 2.79 | 129.22% | ๐ฎ๐ฑ Israel |